USFDA APPLICATION NUMBER - 18647 / DOSAGE - TABLET;ORAL - 5MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Active Ingredient/Active Moiety | ||
Ingredient Name | Basis of Strength | Strength |
---|---|---|
BENDROFLUMETHIAZIDE(UNII: 5Q52X6ICJI) (BENDROFLUMETHIAZIDE - UNII:5Q52X6ICJI) | BENDROFLUMETHIAZIDE | 5mg | 5mg |
NADOLOL(UNII: FEN504330V) (NADOLOL - UNII:FEN504330V) | NADOLOL | 40mg | 80mg |
Inactive Ingredients
Ingredient Name | Pfizer Laboratories Div Pfizer Inc |
---|---|
FD&C BLUE NO. 2(L06K8R7DQK) | |
LACTOSE, UNSPECIFIED FORM(J2B2A4N98G) | |
MAGNESIUM STEARATE(70097M6I30) | |
MICROCRYSTALLINE CELLULOSE(OP1R32D61U) | |
POVIDONE, UNSPECIFIED(FZ989GH94E) | |
SODIUM STARCH GLYCOLATE TYPE A POTATO(5856J3G2A2) |
LOOKING FOR A SUPPLIER?